FIFTH AMENDMENT TO LEASELease • March 15th, 2005 • Dov Pharmaceutical Inc • Pharmaceutical preparations
THIS FIFTH AMENDMENT (the “Amendment”) made as of November 15, 2004, by and between MSNW CONTINENTAL ASSOCIATES, LLC, a Delaware limited liability company, with an office at 67 Park Place East, 8th Floor, Morristown, New Jersey 07960 (“Lessor”) as successor-in-interest to Stellar Continental LLC, and DOV PHARMACEUTICAL, INC., a Delaware corporation, located at 433 Hackensack Avenue, Hackensack, New Jersey 07601 (“Lessee”).
Incentive Stock Option Agreement under the DOV Pharmaceutical, Inc.Incentive Stock Option Agreement • March 15th, 2005 • Dov Pharmaceutical Inc • Pharmaceutical preparations • Delaware
Pursuant to the DOV Pharmaceutical, Inc. 2000 Stock Option and Grant Plan, as amended and restated as of March 28, 2002 (the Plan), DOV Pharmaceutical, Inc., a Delaware corporation (together with all successors thereto, the Company), hereby grants to the Optionee, who is an officer, employee, director, consultant or other key person of the Company or any of its Subsidiaries, an option (the Stock Option) to purchase on or prior to the Expiration Date, or such earlier date as is specified herein, all or any part of the number of shares of Common Stock, par value $0.0001 per share (Common Stock), of the Company indicated above (the Option Shares, and such shares once issued shall be referred to as the Issued Shares), at the Option Exercise Price, subject to the terms and conditions set forth in this Qualified Stock Option Agreement (this Agreement) and in the Plan. This Stock Option is intended to qualify as an incentive stock option as defined in Section 422(b) of the Internal Revenue Co
